GO
Loading...

Takeover Bids

More

  • June 10- Botox maker Allergan Inc on Tuesday rejected a sweetened $53 billion takeover offer from Valeant Pharmaceuticals International and activist investor William Ackman, reiterating that it undervalues the company and is too risky for shareholders.

  • Medtronic CEO: Focused on organic growth     Thursday, 5 Jun 2014 | 3:20 PM ET

    Omar Ishrak, Medtronic chairman & CEO, discusses the state of the health care industry and explains the extensive M&A activity happening in the sector.

  • MELBOURNE, June 5- China's Baosteel Resources and its Australian bidding partner on Thursday set a deadline of July 11 on their $1 billion offer for Aquila Resources Ltd, which they are chasing for its iron ore and coal projects.

  • Unusual options around Hillshire Brands     Tuesday, 3 Jun 2014 | 12:45 PM ET

    FMHR trader Pete Najarian takes a close look at unusual activity in options for Hillshire Brands, and the action in its stock as takeover talks continue.

  • Fight for Hillshire     Tuesday, 3 Jun 2014 | 9:02 AM ET

    Pilgrim's Pride is sweetening its takeover offer for Hillshire Brands. CNBC's Jim Cramer and David Faber discuss the "insane" bidding for Hillshire.

  • June 2- Valeant Pharmaceuticals Inc on Monday prepared to take its $53.8 billion takeover bid for Allergan Inc directly to the Botox maker's shareholders in a battle that could last late into the year. The fight escalated when Valeant ally Pershing Square, a hedge fund that owns 9.7 percent of Allergan, called for a meeting to replace the company's board.

  • June 2- U.S.-based Sterigenics International has sweetened its takeover offer for Nordion Inc, the Canadian medical isotope producer, to $805 million after a previous bid failed to attract enough shareholder support, Nordion said on Monday.

  • June 2- Valeant Pharmaceuticals Inc on Monday prepared to take its $53.8 billion takeover bid for Allergan Inc directly to the Botox maker's shareholders, and ally Pershing Square called for a meeting to turn over the target company's board.

  • Mario Gabelli, Gamco Investors chairman & CEO, shares his thoughts on how to play the social media, e-commerce, and natural gas space.

  • Insurer Endurance raises takeover offer for Aspen Monday, 2 Jun 2014 | 7:36 AM ET

    June 2- Insurer Endurance Specialty Holdings increased its offer for Aspen Insurance Holdings by $2.00 to $49.50 per share after its initial bid was rejected.

  • Gabelli eyes takeover targets     Monday, 2 Jun 2014 | 7:16 AM ET

    Mario Gabelli, Gamco Investors chairman & CEO, explains why he is watching shares of Protective Life, Interpublic Group, and Hillshire Brands.

  • Laval, Quebec- based Valeant said it would pay $72 in cash- up from $58.30 on Wednesday- and 0.83 share of Valeant stock for each Allergan share. The revised, unsolicited offer was triggered by Pershing Square, the hedge fund controlled by Bill Ackman that is Allergan's biggest shareholder, agreeing to take only stock in Valeant for its Allergan shares.

  • Valeant said it would pay $72 in cash- up from $58.30 on Wednesday- and 0.83 share of Valeant stock for each Allergan share. The offer was made possible by Pershing Square, the hedge fund controlled by Bill Ackman that is Allergan's biggest shareholder, agreeing to take only stock in Valeant for its Allergan shares and receive no cash.

  • Cramer: Many reasons to own Tyson     Thursday, 29 May 2014 | 9:08 AM ET

    Tyson Foods is jumping in the takeover battle for Hillshire. The "Squawk on the Street" news team discuss Tyson's $50 a share offer.

  • SYDNEY/ MELBOURNE, May 29- The Australian government cleared on Thursday a $1 billion bid by Chinese state-owned Baosteel Resources for iron ore miner Aquila Resources Ltd, removing the only regulatory hurdle to the deal.

  • 2014: Best M&A year ever?     Wednesday, 28 May 2014 | 3:27 PM ET

    This year has been the year of mergers, acquisitions and hostile takeovers. Attorney Frank Aquila, Sullivan & Cromwell, discusses what's behind the recent M&A boom.

  • Valeant's New York- listed shares dropped 1 percent by midday to $128.66, paring earlier losses, while Allergan stock lost 4.1 percent to $158.29. Valeant on Wednesday offered to pay $58.30 per Allergan share in cash, about $10 higher than its previous offer of $48.30.

  • May 28- Valeant Pharmaceuticals Inc may take its $49.44 billion takeover bid for Botox-maker Allergan Inc directly to the target company's shareholders, Valeant Chief Executive Michael Pearson said on Wednesday.

  • Cramer: Hillshire needs to buy Birds Eye     Wednesday, 28 May 2014 | 9:32 AM ET

    The "Squawk on the Street" take a close look at the offer from Pilgrim's Pride for Hillshire Brands. Pilgrim's Pride wants Hillshire to drop Pinnacle Foods of which Birds Eye Foods is a brand.

  • Valeant needs Allergan deal: Cramer     Wednesday, 28 May 2014 | 9:16 AM ET

    CNBC's David Faber and Jim Cramer discuss the latest M&A action, including Valeant Pharmaceuticals raising its takeover bid for Allergan, and GE improving its offer for France's Alstom.